Class 3. Pulmonary Hypertension Associated with Lung Disease

Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute’s Innovative Drug Development Initiative – Group 3 Pulmonary Hypertension

Lucilla Piccari, Brian Allwood, Katerina Antoniou, Jonathan H. Chung, Paul M. Hassoun, Sylvia M. Nikkho, Rajan Saggar, Oksana A. Shlobin, Patrizio Vitulo, Steven D. Nathan, Stephen John WortHospital del Mar. Stellenbosch University and Tygerberg Hospital. University of Crete School of Medicine. The University of Chicago. Johns Hopkins University. Bayer AG. University of California Los Angeles […]

Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute’s Innovative Drug Development Initiative – Group 3 Pulmonary Hypertension Read More »

Short-time mortality and severe complications of very premature infants-a multicenter retrospective cohort study from Jiangsu Province during 2019-2021

Ya Pan, Huaiyan Wang, Yan Xu, Xiaohua Zhang, Xiaoqing Chen, Xueting Liu, Songlin Liu, Yan Gao, Weiwei Hou, Zhaojun Pan, Xinping Wu, Mei Xue, Mingfu Wu, Huimin Ju, Weimin Wu, Shuping HanWomen’s Hospital of Nanjing Medical University and Nanjing Maternity and Child Health Care Hospital. Changzhou Maternity and Child Health Care Hospital. Affiliated Hospital of

Short-time mortality and severe complications of very premature infants-a multicenter retrospective cohort study from Jiangsu Province during 2019-2021 Read More »

Intravenous sildenafil for treatment of early pulmonary hypertension in preterm infants

Lukas Schroeder, Paulina Monno, Brigitte Strizek, Till Dresbach, Andreas Mueller, Florian KipfmuellerUniversity Children’s Hospital Bonn and University Hospital Bonn.Germany Scientific ReportsSci Rep 2023; 13DOI: 10.1038/s41598-023-35387-y AbstractData is lacking on the effect of continuous intravenous sildenafil treatment in preterm infants with early pulmonary hypertension (PH), especially in very low birth weight (VLBW) infants. Preterm infants (< 37

Intravenous sildenafil for treatment of early pulmonary hypertension in preterm infants Read More »

Evaluation of preterm infants having bronchopulmonary dysplasia with echocardiography and serum biomarkers

O. Pamukcu, N. Narin, S. Sunkak, A. TuncayErciyes University School of Medicıne.Turkey Cardiology in the YoungCardiol Young 2023; DOI: 10.1017/S1047951123001361 AbstractBackground and objectives: Pulmonary hypertension is frequent in infants with bronchopulmonary dysplasia. Echocardiography is easy to perform, non-invasive, and recommended by guidelines even though solely it is not enough. Catheterisation is gold standard but invasive, expensive, and

Evaluation of preterm infants having bronchopulmonary dysplasia with echocardiography and serum biomarkers Read More »

Efficacy of Sildenafil in Infants with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension

Kacie Dillon, Vineet Lamba, Ranjit R. Philip, Mark F. Weems, Ajay J. Talati University of Tennessee Health Science Center.United States ChildrenChildren 2023; DOI: 10.3390/children10081397 AbstractBackground: Pulmonary hypertension (PH) is a common comorbidity in infants with bronchopulmonary dysplasia (BPD). Sildenafil is a widely recognized therapy for PH, but its efficacy in infants with BPD is questionable. We propose

Efficacy of Sildenafil in Infants with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension Read More »

The role of rhIGF-1/BP3 in the prevention of pulmonary hypertension in bronchopulmonary dysplasia and its underlying mechanism

Sehua Qu, Lianqiang Shan, Xin Chen, Zhen Zhang, Yumeng Wu, Yun Chen, Feixiang Zhuo, Yitong Wang, Huaifu DongThe First Affiliated Hospital of Bengbu Medical College. China BioMed Central Pulmonary MedicineBMC Pulm Med 2023; 23: DOI: 10.1186/s12890-023-02498-1 AbstractBackground: This study aimed to determine whether postnatal treatment with recombinant human IGF-1 (rhIGF-1)/binding peptide 3 (BP3) ameliorates lung injury and

The role of rhIGF-1/BP3 in the prevention of pulmonary hypertension in bronchopulmonary dysplasia and its underlying mechanism Read More »

Evaluation of Postnatal Complications in Clinical and Histological Chorioamnionitis in Extremely Preterm Infants: A Japanese Cohort Study

Shuji Ishida, Hidehiko Nakanishi, Rika Sekiya, Kohei Kawada, Yukako Kosaka, Ayano Yamaguchi, Mari Ooka, On befalf of the Neonatal Research Network of JapanKitasato University.Japan American Journal of PerinatologyAm J Perinatol 2023; DOI: 10.1055/a-2113-4332 AbstractObjective: Terminating pregnancy appropriately before the intrauterine infection has progressed may have an improved prognosis for preterm infants. We evaluate how the combination of histological chorioamnionitis (hCAM) and clinical chorioamnionitis

Evaluation of Postnatal Complications in Clinical and Histological Chorioamnionitis in Extremely Preterm Infants: A Japanese Cohort Study Read More »

Pulmonary hypertension among preterm infants born at 22 through 32 weeks gestation in France: Prevalence, survival, morbidity and management in the EPIPAGE-2 cohort study

Sophie Breinig, Virginie Ehlinger, Jean-Christophe Roze, Laurent Storme, Heloise Torchin, Xavier Durrmeyer, Gilles Cambonie, Christophe Delacourt, Pierre-Henri Jarreau, Lionel Berthomieu, Olivier Brissaud, Valerie Benhammou, Geraldine Gascoinb, Catherine Arnaud, Pierre-Yves AnceljChildren’s Hospital and Toulouse University. Nantes University Hospital. Lille University Hospital. Assistance Publique-Hôpitaux de Paris. CHI Créteil. Montpellier University Hospital. Necker Children’s Hospital. Bordeaux University Hospital.

Pulmonary hypertension among preterm infants born at 22 through 32 weeks gestation in France: Prevalence, survival, morbidity and management in the EPIPAGE-2 cohort study Read More »

Two-stage learning-based prediction of bronchopulmonary dysplasia in very low birth weight infants: a nationwide cohort study

Jae Kyoon Hwang, Dae Hyun Kim, Jae Yoon Na, Joonhyuk Son, Yoon Ju Oh, Donggoo Jung, Chang-Ryul Kim, Tae Hyun Kim, Hyun-Kyung ParkHanyang University College of Medicine and Hanyang University.Republic of Korea Frontiers in PediatricsFront Pediat 2023; 11DOI: 10.3389/fped.2023.1155921 AbstractIntroduction: The aim of this study is to develop an enhanced machine learning-based prediction models for bronchopulmonary dysplasia

Two-stage learning-based prediction of bronchopulmonary dysplasia in very low birth weight infants: a nationwide cohort study Read More »

Neurodevelopmental Outcomes of Preterm Infants Born <29 Weeks with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Multicenter Study

Soumya R. Thomas, Sunil K. Jain, Prashanth Murthy, Chacko J. Joseph, Amuchou Soraisham, Selphee Tang, Aliyah Dosani, Abhay LodhaUniversity of Calgary and Alberta Children’s Hospital. University of Texas Medical Branch. Mount Royal University.Canada and United States American Journal of PerinatologyAm J Perinatol 2023; DOI: 10.1055/a-2121-8878 AbstractObjective: This study aimed to determine neurodevelopmental outcomes of preterm infants born

Neurodevelopmental Outcomes of Preterm Infants Born <29 Weeks with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Multicenter Study Read More »

Scroll to Top